التفاصيل البيبلوغرافية
| العنوان: |
Phase II Study of the MEK1/MEK2 Inhibitor Trametinib in Patients With Metastatic BRAF-Mutant Cutaneous Melanoma Previously Treated With or Without a BRAF Inhibitor. |
| المؤلفون: |
Kim, Kevin B., Kefford, Richard, Pavlick, Anna C., Infante, Jeffrey R., Ribas, Antoni, Sosman, Jeffrey A., Fecher, Leslie A., Millward, Michael, McArthur, Grant A., Hwu, Patrick, Gonzalez, Rene, Ott, Patrick A., Long, Georgina V., Gardner, Olivia S., Ouellet, Daniele, Yanmei Xu, DeMarini, Douglas J., Le, Ngocdiep T., Patel, Kiran, Lewis, Karl D. |
| المصدر: |
Journal of Clinical Oncology; 2/1/2013, Vol. 31 Issue 4, p482-489, 8p |
| قاعدة البيانات: |
Supplemental Index |
